BFLY Butterfly Network, Inc.
X-Ray Apparatus & Tubes & Related Irradiation Apparatus · NYSE · SEC CIK 1804176 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY39.4%
TTM net income YoY32.8%
TTM EPS YoY36.4%
Revenue 3-yr CAGR21.7%
Net income 3-yr CAGR—
Margins
Gross margin70.3%
Operating margin-46.9%
Net margin-43.6%
FCF margin-22.4%
EBITDA margin—
Returns
ROE-27.7%
ROA-18.6%
ROIC (approx.)-75.1%
Asset turnover0.43x
Leverage & solvency
Liabilities / assets36.0%
Debt / equity0.00x
Current ratio3.58x
Interest coverage-46.82x
Cash quality & payout
Operating cash flow / net income0.44x
Accruals ratio-10.5%
Payout ratio—
Capex / revenue3.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $32.60M | $32.61M | $26.53M | $31.51M | $21.49M | $23.38M | $21.23M | $22.35M |
| Cost of revenue | $8.80M | $9.32M | $8.24M | $10.29M | $25.25M | $8.49M | $7.84M | $8.62M |
| Gross profit | $23.80M | $23.29M | $18.29M | $21.22M | -$3.76M | $14.89M | $13.38M | $13.73M |
| R&D expense | $10.17M | $10.54M | $9.54M | $9.32M | $8.70M | $8.31M | $9.92M | $8.82M |
| SG&A expense | $11.56M | $11.36M | $10.82M | $11.22M | $9.29M | $9.13M | $9.60M | $9.94M |
| Operating income | -$13.58M | -$13.66M | -$13.87M | -$16.71M | -$35.13M | -$16.10M | -$18.47M | -$17.31M |
| Interest expense | $284,000 | $282,000 | $279,000 | $390,000 | $385,000 | $368,000 | $347,000 | $333,000 |
| Pretax income | -$12.81M | -$12.91M | -$12.68M | -$15.22M | -$33.95M | -$13.81M | -$13.96M | -$18.21M |
| Income tax | $0 | $0 | $0 | $67,000 | $16,000 | $20,000 | $7,000 | -$110,000 |
| Net income | -$12.81M | -$12.91M | -$12.68M | -$15.29M | -$33.97M | -$13.83M | -$13.97M | -$18.10M |
| EPS (basic) | -0.05 | -0.05 | -0.05 | — | -0.13 | -0.06 | -0.06 | — |
| EPS (diluted) | -0.05 | -0.05 | -0.05 | — | -0.13 | -0.06 | -0.06 | — |
| Weighted avg. shares (diluted) | 266.50M | 262.10M | 256.52M | — | 252.09M | 248.39M | 234.92M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $122.30M | $124.66M | $137.95M | $150.49M | $144.23M | $148.14M | $155.21M | $92.79M |
| Receivables | $37.38M | $34.55M | $25.21M | $26.74M | $24.42M | $24.53M | $19.88M | $20.79M |
| Inventory | $59.58M | $58.56M | $59.30M | $61.39M | $62.23M | $68.91M | $69.31M | $70.79M |
| Current assets | $243.67M | $237.95M | $239.79M | $249.10M | $241.39M | $253.75M | $257.38M | $192.61M |
| PP&E, net | $15.85M | $15.85M | $16.11M | $16.59M | $16.85M | $17.33M | $17.98M | $19.52M |
| Intangibles | $6.47M | $6.82M | $7.17M | $7.52M | $7.87M | $8.22M | $8.57M | $8.92M |
| Total assets | $287.98M | $283.00M | $285.92M | $296.53M | $290.00M | $313.28M | $318.41M | $256.08M |
| Current liabilities | $67.99M | $58.60M | $59.58M | $65.12M | $50.33M | $44.67M | $42.48M | $48.22M |
| Total liabilities | $103.53M | $93.59M | $94.70M | $100.55M | $86.17M | $80.47M | $78.72M | $87.25M |
| Shareholders' equity | $184.44M | $189.40M | $191.22M | $195.98M | $203.83M | $232.81M | $239.70M | $168.83M |
| Cash flow statement | ||||||||
| Operating cash flow | -$2.27M | -$16.27M | -$13.89M | $9.03M | -$2.89M | -$7.17M | -$11.68M | -$3.12M |
| Capital expenditure | $1.15M | $974,000 | $950,000 | $1.08M | $1.02M | $896,000 | $353,000 | $408,000 |
| Free cash flow | -$3.41M | -$17.24M | -$14.84M | $7.95M | -$3.90M | -$8.06M | -$12.03M | -$3.53M |
| Investing cash flow | -$1.15M | -$974,000 | -$950,000 | -$1.08M | -$1.02M | -$896,000 | -$353,000 | -$408,000 |
| Financing cash flow | $1.05M | $3.95M | $2.31M | -$1.69M | $0 | $987,000 | $78.47M | -$1.50M |
| Stock-based compensation | $6.73M | $7.04M | $5.54M | $6.36M | $4.92M | $5.86M | $6.28M | $5.24M |
Free plan shows the latest 8 periods; Pro shows all 27 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.